Docobo has announced the release of its latest version of cardiovascular monitoring functionality, which provides the opportunity to screen, assess and potentially detect undiagnosed atrial fibrillation (AF) and hypertension, two conditions strongly associated with an increased risk of stroke.

Docobo is working with a number of clients to roll out this screening capability. By incorporating brief assessments for AF and hypertension, individuals at increased risk of stroke, can be identified and guided to preventative care pathways.

Stroke is a leading cause of death and disability worldwide and early detection and management of risk factors are crucial in preventing its occurrence. Hypertension affects a significant portion of the UK population, and if left untreated, it can lead to severe complications such as stroke, heart failure, and kidney disease, while undiagnosed atrial fibrillation poses a substantial risk, as it increases the likelihood of developing blood clots, which can cause life-threatening conditions like stroke or pulmonary embolism.

Peter Levene, Docobo says: ‘By identifying undiagnosed AF and hypertension, we can help individuals take necessary steps to reduce their stroke risk. Together with the NHS, we can make a substantial difference in the lives of individuals affected by hypertension and undiagnosed atrial fibrillation, particularly in the clinical area of stroke prevention.’

Adrian Flowerday, Managing Director of Docobo says ‘Docobo is in a unique position to facilitate preventative actions and has a system in place to support NHS care pathways to reduce the occurrence of stroke in at-risk, local and regional populations.’